Fifth Third Bancorp
PBE icon

Fifth Third Bancorp’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Fifth Third Bancorp’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.2K Buy
460
+82
+22% +$6.75K ﹤0.01% 3295
2026
Q1 		$29.9K Buy
+378
New +$30.6K ﹤0.01% 3380
2014
Q1 		– Sell
-500
Closed -$19K – 2353
2013
Q4 		$19K Hold
500
– – ﹤0.01% 1682
2013
Q3 		$18K Buy
+500
New +$16.6K ﹤0.01% 1708

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.75B AUM 28.61% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Fifth Third Bancorp's PBE Position: Q2 2026 in Review

Fifth Third Bancorp increased its Invesco Biotechnology & Genome ETF (PBE) stake by 22% in Q2 2026, buying an estimated $6.75K and bringing the position to 460 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3295.

Fifth Third Bancorp first reported a position in PBE in Q3 2013 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

  • Fifth Third Bancorp held 460 shares of Invesco Biotechnology & Genome ETF worth $41.2K as of Q2 2026.
  • Fifth Third Bancorp bought 82 Invesco Biotechnology & Genome ETF shares in Q2 2026, an estimated $6.75K.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3295 holding.
  • Fifth Third Bancorp first reported a position in Invesco Biotechnology & Genome ETF in Q3 2013 and has held it in 4 quarters since.
  • 105 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.